AI Moves From Lab Curiosity to Cancer Care’s New Backbone
A new review maps how artificial intelligence is transforming oncology drug discovery, clinical decision-making, and regulatory science from molecule design ...
A new review maps how artificial intelligence is transforming oncology drug discovery, clinical decision-making, and regulatory science from molecule design ...
A 58-article special issue of Molecular Diversity shows how synthetic chemistry, protein degraders, natural products, and AI-driven screening are converging ...
Researchers combined machine learning and deep learning with multiple molecular fingerprints to build predictive models that identified two promising topoisomerase ...
A new systematic review reveals how artificial intelligence, generative models, and quantum computing are converging to transform drug discovery and ...
Insilico Medicine executives will speak at premier healthcare and AI summits in New York, Riyadh, Shanghai and Boston this September, ...
An AI-driven screening pipeline identified the fungal sterol 5,6-epoxyergosterol as a selective LXRβ agonist that exploits the cholesterol dependency of ...
Alex Aliper, PhD, Co-founder and President of Insilico Medicine, is set to bring the rapidly evolving science of generative artificial ...
Insilico Medicine has been nominated for the 2026 Prix Galien USA “Best Start-Up” Award in the Biotechnology category, marking the ...
Insilico Medicine founders Dr. Alex Zhavoronkov and Dr. Feng Ren have been invited to the inaugural China Pioneer Innovative Drug ...
Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine